Insider Trading25 Jun 2026, 03:17 pm
Aurobindo Pharma Closes Trading Window for Q1 FY27 Results
AI Summary
Aurobindo Pharma Ltd has announced the closure of its trading window for all designated persons, including promoters, directors, and key managerial personnel. This closure is in accordance with the company's Internal Code of Conduct for trading in securities. The window will be shut from July 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the first quarter ending June 30, 2026. The specific date for the Board Meeting to approve these results will be communicated later.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from July 1, 2026.
- Window reopens 48 hours post Q1 FY27 results declaration.
- Purpose is to prevent insider trading during financial reporting.
Price Impact
More from AUROPHARMA